InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,196.80
(
0.11%
)
Dow Jones
39,112.16
(
0.00%
)
Brent Oil
84.74
(
0.65%
)
Bitcoin
61,443.36
(
-0.59%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

QyQ

Send PM Follow Ignore
Followers 0
Posts 61
Boards Moderated 0
Alias Born 04/13/2013

QyQ

Re: nutsyprofessor post# 25307

Tuesday, 04/16/2013 8:31:53 AM

Tuesday, April 16, 2013 8:31:53 AM

Post# of 26138
Guys.

ANI got $20m revenue VS BPAX got $200m at least for 4+ million off-label prescriptions alone.

Pls do your maths. BPAX is 10X worth more than ANI.

Some more BPAX no need to have manufacturing plant at all (profit margin increase due to low cost). Just contract manufacturing to ANI and then can sell Libigel already...

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up